Anesthesiology
Anesthesiology
Audio Summaries
The literature in anesthesiology doesn't slow down, and the papers you skip might be the ones that change your practice. OSLR turns the journals you'd read if you had the time into 3-minute audio summaries. Listen on your commute, between cases, whenever.
Journals in Anesthesiology
Active journals with audio summaries available on OSLR.
Anaesthesia
Anesthesiology
British journal of anaesthesia
Critical care medicine
Journal of addiction medicine
Journal of palliative medicine
JPEN. Journal of parenteral and enteral nutrition
Lancet
Lancet (London, England)
Paediatric anaesthesia
Pain
Regional anesthesia and pain medicine
The New England journal of medicine
Recent summaries
The latest articles summarized from anesthesiology journals.
Prevention and Treatment of Peanut Allergy
This paper investigates the effectiveness of early peanut protein introduction and immunotherapy in preventing and treating peanut allergy. The authors find that introducing peanut protein early significantly reduces allergy prevalence, with optimal prevention strategies differing for low and high-risk infants. Additionally, they highlight that immunotherapy is more effective when started in younger children, emphasizing the critical need for early intervention.
Efficacy and safety of tirofiban after successful endovascular reperfusion in acute ischaemic stroke (ATTRACTION) in China: a multicentre, double-blind, randomised controlled trial
The authors aimed to evaluate the efficacy and safety of tirofiban, a glycoprotein IIb/IIIa receptor antagonist, in improving functional independence in patients with acute ischaemic stroke following successful endovascular reperfusion. In a multicentre, double-blind, randomized controlled trial involving 1,380 patients, tirofiban was found to significantly increase the likelihood of functional independence at 90 days compared to placebo, although there was no significant difference in the rates of symptomatic intracranial hemorrhage or mortality between the two groups.
Ten-Year Outcomes after CAR T-Cell Therapy for B-Cell Lymphomas
The authors aimed to evaluate the long-term outcomes of anti-CD19 CAR T-cell therapy (tisagenlecleucel) in patients with relapsed or refractory B-cell non-Hodgkin lymphomas over a median follow-up of 10.1 years. They found that approximately 32% of patients with large B-cell lymphoma and 47% with follicular lymphoma achieved lymphoma-free survival, with a notable persistence of B-cell aplasia in long-term responders. The study highlights the potential for durable remissions in this patient population, despite some risks of non-relapse-related mortality and secondary cancers.
A Pragmatic Trial of a 6-Month Strategy for Rifampicin-Resistant Tuberculosis
The authors aimed to evaluate the efficacy and safety of a 6-month treatment regimen for pulmonary rifampicin-resistant tuberculosis compared to the standard 9-month treatment in South Africa. The study found that the 6-month regimen was noninferior in achieving successful treatment outcomes and had a similar safety profile to the standard regimen. This suggests that the shorter treatment duration may be a viable alternative for managing rifampicin-resistant tuberculosis.
Ethical Implications of the Slow Code: A Systematic Review of Ethics of Slow Codes in U.S. Hospitals
The authors investigate the ethical implications of "slow codes" in U.S. hospitals, where clinicians perform resuscitation efforts without full commitment, often in response to patient or family requests despite the futility of such interventions. Their systematic review of 34 studies reveals a significant divide among physicians regarding the permissibility of slow codes, with most ethics literature deeming them impermissible due to concerns about deception, patient autonomy, and moral distress. The findings underscore the need for improved communication and ethical guidance in navigating end-of-life care decisions.
Safety, pharmacokinetics, and exploratory efficacy of the oral ghrelin receptor agonist AC01 in heart failure with reduced ejection fraction (GOAL-HF1): a randomised, double-blind, placebo-controlled, phase 1b/2a study
This study aimed to evaluate the safety, tolerability, and preliminary efficacy of AC01, an oral ghrelin receptor agonist, in patients with heart failure with reduced ejection fraction (HFrEF). The results indicated that AC01 was generally safe and well tolerated over 28 days, with no major adverse events reported, suggesting potential for further investigation in larger trials.
Medicaid Prior Authorization and Discontinuation of Buprenorphine
The authors investigate how Medicaid's utilization management policies, specifically prior authorization (PA), affect the duration of buprenorphine treatment episodes for opioid use disorder. Their analysis of national prescription claims data reveals that buprenorphine discontinuation rates are high across all Medicaid plans, with a notable decline in treatment continuation observed within the first three months, particularly among managed care organization (MCO) plans with PA. The findings suggest a need for further research into additional insurer policies that may impact treatment adherence.
Trends in Public Opinion About US Illicit Drug Policy: Results From the 2000 to 2025 Gallup Survey
This study investigates American perceptions of progress in illicit drug policy and the severity of the drug problem from 2000 to 2025, utilizing data from the Gallup Poll Social Survey. The findings reveal that less than half of Americans consistently perceive progress against illicit drugs, with significant partisan differences influencing these perceptions, particularly in the context of political leadership. The authors highlight that increasing political polarization may hinder the development of a unified national drug control strategy.
Implementation of Dyadic Care to Support Clinical, Administrative, and Service Wraparound Needs for the Opioid-Exposed Mother and Infant
The authors aimed to evaluate the implementation of dyadic care models for opioid-exposed mothers and infants, addressing the lack of practical guidance in this area. Through a comparative analysis of five outpatient programs, they identified commonalities and differences in clinical, administrative, and service wraparound practices, revealing that while dyadic care is consistently defined, its operationalization varies significantly. The study highlights key elements that can enhance the effectiveness of dyadic care despite existing challenges related to funding, coordination, and resource limitations.
Impact of continuous serratus plane analgesia on quality of recovery after video-assisted thoracic surgery: a prospective double-blind, randomized, placebo-controlled trial
The authors aimed to determine whether continuous serratus anterior plane block (SAPB) infusion, combined with multimodal analgesia, could enhance the quality of recovery (QoR-40) after video-assisted thoracoscopic surgery (VATS). Although the SAPB group showed higher QoR-40 scores and reduced opioid consumption compared to the control group, these differences were not statistically significant for the primary outcome. The study concludes that while continuous SAPB may have some benefits, larger trials are needed to confirm its impact on patient-reported recovery.
